(1)
Tadayasu, Y.; Sarashina, A.; Tsuda, Y.; Tatami, S.; Friedrich, C.; Retlich, S.; Staab, A.; Takano, M. Population Pharmacokinetic Pharmacodynamic Analysis of the DPP-4 Inhibitor Linagliptin in Japanese Patients With Type 2 Diabetes Mellitus. J Pharm Pharm Sci 2013, 16, 708-721.